548 related articles for article (PubMed ID: 17169479)
1. The corticostriatal pathway in Huntington's disease.
Cepeda C; Wu N; André VM; Cummings DM; Levine MS
Prog Neurobiol; 2007 Apr; 81(5-6):253-71. PubMed ID: 17169479
[TBL] [Abstract][Full Text] [Related]
2. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.
Kolodziejczyk K; Raymond LA
Neurobiol Dis; 2016 Feb; 86():62-74. PubMed ID: 26621114
[TBL] [Abstract][Full Text] [Related]
3. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
Parievsky A; Moore C; Kamdjou T; Cepeda C; Meshul CK; Levine MS
Neurobiol Dis; 2017 Dec; 108():29-44. PubMed ID: 28757327
[TBL] [Abstract][Full Text] [Related]
4. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
Buren C; Parsons MP; Smith-Dijak A; Raymond LA
Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
[TBL] [Abstract][Full Text] [Related]
5. Functional interactions within striatal microcircuit in animal models of Huntington's disease.
Ghiglieri V; Bagetta V; Calabresi P; Picconi B
Neuroscience; 2012 Jun; 211():165-84. PubMed ID: 21756979
[TBL] [Abstract][Full Text] [Related]
6. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Cepeda C; Hurst RS; Calvert CR; Hernández-Echeagaray E; Nguyen OK; Jocoy E; Christian LJ; Ariano MA; Levine MS
J Neurosci; 2003 Feb; 23(3):961-9. PubMed ID: 12574425
[TBL] [Abstract][Full Text] [Related]
7. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
Laforet GA; Sapp E; Chase K; McIntyre C; Boyce FM; Campbell M; Cadigan BA; Warzecki L; Tagle DA; Reddy PH; Cepeda C; Calvert CR; Jokel ES; Klapstein GJ; Ariano MA; Levine MS; DiFiglia M; Aronin N
J Neurosci; 2001 Dec; 21(23):9112-23. PubMed ID: 11717344
[TBL] [Abstract][Full Text] [Related]
8. Disrupted striatal neuron inputs and outputs in Huntington's disease.
Reiner A; Deng YP
CNS Neurosci Ther; 2018 Apr; 24(4):250-280. PubMed ID: 29582587
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Joshi PR; Wu NP; André VM; Cummings DM; Cepeda C; Joyce JA; Carroll JB; Leavitt BR; Hayden MR; Levine MS; Bamford NS
J Neurosci; 2009 Feb; 29(8):2414-27. PubMed ID: 19244517
[TBL] [Abstract][Full Text] [Related]
10. Corticostriatal synaptic adaptations in Huntington's disease.
Plotkin JL; Surmeier DJ
Curr Opin Neurobiol; 2015 Aug; 33():53-62. PubMed ID: 25700146
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.
Rangel-Barajas C; Rebec GV
J Huntingtons Dis; 2016 Dec; 5(4):303-331. PubMed ID: 27983564
[TBL] [Abstract][Full Text] [Related]
12. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
[TBL] [Abstract][Full Text] [Related]
13. Cortico-Striatal Cross-Frequency Coupling and Gamma Genesis Disruptions in Huntington's Disease Mouse and Computational Models.
Naze S; Humble J; Zheng P; Barton S; Rangel-Barajas C; Rebec GV; Kozloski JR
eNeuro; 2018; 5(6):. PubMed ID: 30627632
[TBL] [Abstract][Full Text] [Related]
14. Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.
Indersmitten T; Tran CH; Cepeda C; Levine MS
J Neurophysiol; 2015 Apr; 113(7):2953-66. PubMed ID: 25673747
[TBL] [Abstract][Full Text] [Related]
15. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease.
Dorner JL; Miller BR; Klein EL; Murphy-Nakhnikian A; Andrews RL; Barton SJ; Rebec GV
Brain Res; 2009 Sep; 1290():111-20. PubMed ID: 19616518
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
Raymond LA; André VM; Cepeda C; Gladding CM; Milnerwood AJ; Levine MS
Neuroscience; 2011 Dec; 198():252-73. PubMed ID: 21907762
[TBL] [Abstract][Full Text] [Related]
17. Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.
Plotkin JL; Day M; Peterson JD; Xie Z; Kress GJ; Rafalovich I; Kondapalli J; Gertler TS; Flajolet M; Greengard P; Stavarache M; Kaplitt MG; Rosinski J; Chan CS; Surmeier DJ
Neuron; 2014 Jul; 83(1):178-88. PubMed ID: 24991961
[TBL] [Abstract][Full Text] [Related]
18. Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.
Deng YP; Wong T; Bricker-Anthony C; Deng B; Reiner A
Neurobiol Dis; 2013 Dec; 60():89-107. PubMed ID: 23969239
[TBL] [Abstract][Full Text] [Related]
19. Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease.
Galvan L; André VM; Wang EA; Cepeda C; Levine MS
J Huntingtons Dis; 2012; 1(1):17-25. PubMed ID: 25063187
[TBL] [Abstract][Full Text] [Related]
20. Role of cerebral cortex in the neuropathology of Huntington's disease.
Estrada-Sánchez AM; Rebec GV
Front Neural Circuits; 2013; 7():19. PubMed ID: 23423362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
